Tiffany Thorn
Founder presso BIVICTRIX THERAPEUTICS PLC
Patrimonio netto: 232 011 $ in data 31/03/2024
Posizioni attive di Tiffany Thorn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIVICTRIX THERAPEUTICS PLC | Director/Board Member | 01/01/2016 | - |
| Chief Executive Officer | 01/01/2016 | - | |
| Founder | 01/01/2016 | - |
Storia della carriera di Tiffany Thorn
Precedenti posizioni note di Tiffany Thorn
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MOTIF BIO PLC | Director/Board Member | 14/06/2021 | - |
| Chief Executive Officer | 14/06/2021 | - |
Formazione di Tiffany Thorn
| The University of Manchester | Graduate Degree |
| University of Lancaster | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
Posizioni
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Founder | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIVICTRIX THERAPEUTICS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Motif Bio Plc
 Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Tiffany Thorn
- Esperienza
